» Articles » PMID: 19778295

Lower Numbers of Circulating Natural Killer T (NK T) Cells in Individuals with Human T Lymphotropic Virus Type 1 (HTLV-1) Associated Neurological Disease

Overview
Date 2009 Sep 26
PMID 19778295
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Human T lymphotropic virus type 1 (HTLV-1) infects 10-20 million people worldwide. The majority of infected individuals are asymptomatic; however, approximately 3% develop the debilitating neurological disease HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). There is also currently no cure, vaccine or effective therapy for HTLV-1 infection, and the mechanisms for progression to HAM/TSP remain unclear. NK T cells are an immunoregulatory T cell subset whose frequencies and effector functions are associated critically with immunity against infectious diseases. We hypothesized that NK T cells are associated with HAM/TSP progression. We measured NK T cell frequencies and absolute numbers in individuals with HAM/TSP infection from two cohorts on two continents: São Paulo, Brazil and San Francisco, CA, USA, and found significantly lower levels when compared with healthy subjects and/or asymptomatic carriers. Also, the circulating NK T cell compartment in HAM/TSP subjects is comprised of significantly more CD4(+) and fewer CD8(+) cells than healthy controls. These findings suggest that lower numbers of circulating NK T cells and enrichment of the CD4(+) NK T subset are associated with HTLV-1 disease progression.

Citing Articles

Comprehensive Insight into the Functional Roles of NK and NKT Cells in HTLV-1-Associated Diseases and Asymptomatic Carriers.

Mahdifar M, Boostani R, Taylor G, Rezaee S, Rafatpanah H Mol Neurobiol. 2024; 61(10):7877-7889.

PMID: 38436833 DOI: 10.1007/s12035-024-03999-8.


Invariant Natural Killer T-cells and their subtypes may play a role in the pathogenesis of endometriosis.

Correa F, Andres M, Rocha T, Carvalho A, Aloia T, Corpa M Clinics (Sao Paulo). 2022; 77:100032.

PMID: 35576870 PMC: 9118517. DOI: 10.1016/j.clinsp.2022.100032.


The Role of NK Cells in the Control of Viral Infection in HTLV-1 Carriers.

Amorim C, Carvalho N, Abraao Neto J, Santos S, Grassi M, Carvalho L J Immunol Res. 2019; 2019:6574828.

PMID: 30944834 PMC: 6421729. DOI: 10.1155/2019/6574828.


MAIT cells are reduced in frequency and functionally impaired in human T lymphotropic virus type 1 infection: Potential clinical implications.

Paquin-Proulx D, Greenspun B, Costa E, Segurado A, Kallas E, Nixon D PLoS One. 2017; 12(4):e0175345.

PMID: 28384290 PMC: 5383303. DOI: 10.1371/journal.pone.0175345.


The Impact of Immune Response on HTLV-I in HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).

Rafatpanah H, Hosseini R, Pourseyed S Iran J Basic Med Sci. 2014; 16(3):235-41.

PMID: 24470869 PMC: 3881240.


References
1.
Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A . HTLV-I associated myelopathy, a new clinical entity. Lancet. 1986; 1(8488):1031-2. DOI: 10.1016/s0140-6736(86)91298-5. View

2.
Jacobson S . Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease. J Infect Dis. 2002; 186 Suppl 2:S187-92. DOI: 10.1086/344269. View

3.
Gumperz J, Miyake S, Yamamura T, Brenner M . Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J Exp Med. 2002; 195(5):625-36. PMC: 2193772. DOI: 10.1084/jem.20011786. View

4.
Gessain A, Barin F, Vernant J, Gout O, Maurs L, Calender A . Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet. 1985; 2(8452):407-10. DOI: 10.1016/s0140-6736(85)92734-5. View

5.
Sugawara I, Yamada H, Mizuno S, Li C, Nakayama T, Taniguchi M . Mycobacterial infection in natural killer T cell knockout mice. Tuberculosis (Edinb). 2002; 82(2-3):97-104. DOI: 10.1054/tube.2002.0331. View